Letermovir Treatment for Refractory or Resistant Cytomegalovirus Infection
Clinical trial NCT03728426 · COMPLETED
Trial details
- NCT number
- NCT03728426
- Sponsor
- Amy C. Sherman, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-11
- Primary completion
- 2022-03-28
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.